MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) Shareholders’ equity 2016–2024
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) shareholders’ equity at each fiscal year-end, per SEC filings.
$19.2MFY2024 · since FY2016: $6.1M → $19.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $19.2M | -47.5% |
| FY2023 | $36.6M | -30.2% |
| FY2022 | $52.5M | -17.6% |
| FY2021 | $63.7M | +92.8% |
| FY2020 | $33.1M | +104.8% |
| FY2019 | $16.1M | +51.1% |
| FY2018 | $10.7M | +49.4% |
| FY2017 | $7.1M | +17.7% |
| FY2016 | $6.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice